Primary Aldosteronism | HBP Guideline | JACC

JACC's November 4 issue features the High Blood Pressure Guideline surrounded by a series of expert commentaries. In this video interview, JACC Deputy Editor Erica S. Spatz, MD, FACC, speaks with author Anand Vaidya, MD MMSc. Listen in for an insider view of the evolving understanding of primary aldosteronism in light of the 2025 high blood pressure guidelines. Dr. Vaidya emphasizes that primary aldosteronism may be a common, modifiable contributor to hypertension—potentially affecting up to 25% of patients—and advocates for simplified diagnostic approaches and broader use of mineralocorticoid receptor antagonists to improve outcomes.